Boland Barry, Nixon Ralph A
Department of Pharmacology, Oxford University, Oxford OX13QT, United Kingdom.
Mol Aspects Med. 2006 Oct-Dec;27(5-6):503-19. doi: 10.1016/j.mam.2006.08.009. Epub 2006 Sep 26.
Macroautophagy, a lysosomal pathway responsible for the turnover of organelles and long-lived proteins, has been regarded mainly as an inducible process in neurons, which is mobilized in states of stress and injury. New studies show, however, that macroautophagy is also constitutively active in healthy neurons and is vital to cell survival. Neurons in the brain, unlike cells in the periphery, are protected from large-scale autophagy induction because they can use several different energy sources optimally, receive additional nutrients and neurotrophin support from glial cells, and benefit from hypothalamic regulation of peripheral nutrient supplies. Due to its exceptional efficiency, constitutive autophagy in healthy neurons proceeds in the absence of easily detectable autophagic vacuole intermediates. These intermediates can accumulate rapidly, however, when late steps in the autophagic process are blocked. Autophagic vacuoles also accumulate abnormally in affected neurons of several major neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease, where they have been linked to various aspects of disease pathogenesis including neuronal cell death. The build-up of autophagic vacuoles in these neurological disorders and others may reflect either heightened autophagy induction, impairment in later digestive steps in the autophagy pathway, or both. Determining the basis for AV accumulation is critical for understanding the pathogenic significance of autophagy in a given pathologic state and for designing possible therapies based on modulating autophagy. In this review, we discuss the special features of autophagy regulation in the brain, its suspected roles in neurodevelopment and plasticity, and recent progress toward understanding how dysfunctional autophagy contributes to neurodegenerative disease.
巨自噬是一种负责细胞器和长寿蛋白周转的溶酶体途径,在神经元中主要被视为一种可诱导的过程,在应激和损伤状态下被激活。然而,新的研究表明,巨自噬在健康神经元中也具有组成性活性,对细胞存活至关重要。与外周细胞不同,大脑中的神经元受到保护,不会发生大规模自噬诱导,因为它们可以最佳地利用几种不同的能量来源,从神经胶质细胞获得额外的营养和神经营养因子支持,并受益于下丘脑对外周营养供应的调节。由于其卓越的效率,健康神经元中的组成性自噬在没有易于检测到的自噬泡中间体的情况下进行。然而,当自噬过程的后期步骤被阻断时,这些中间体可以迅速积累。自噬泡在包括阿尔茨海默病和帕金森病在内的几种主要神经退行性疾病的受影响神经元中也异常积累,在这些疾病中,它们与疾病发病机制的各个方面有关,包括神经元细胞死亡。这些神经疾病和其他疾病中自噬泡的积累可能反映了自噬诱导增强、自噬途径后期消化步骤受损,或两者兼而有之。确定自噬泡积累的基础对于理解自噬在特定病理状态下的致病意义以及设计基于调节自噬的可能疗法至关重要。在这篇综述中,我们讨论了大脑中自噬调节的特殊特征、其在神经发育和可塑性中的推测作用,以及在理解功能失调的自噬如何导致神经退行性疾病方面的最新进展。